GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we handle diabetes mellitus . These injectable drugs work by stimulating the body’s inherent GLP-1 process, which https://pr8bookmarks.com/story21863405/glp-1-a-significant-advance-in-blood-sugar-care